ABCB1 Polymorphisms and Cold Pressor Pain Responses: Opioid-Dependent Patients on Methadone Maintenance Therapy

Nursing Research

Volumn 66, Issue 2, 2017, Pages 134-144

  Zahari, Zalina ^a,b   Lee, Chee Siong ^c   Ibrahim, Muslih Abdulkarim ^d   Musa, Nurfadhlina ^b   Mohd Yasin, Mohd Azhar ^b   Lee, Yeong Yeh ^b   Tan, Soo Choon ^d   Mohamad, Nasir ^e   Ismail, Rusli ^f  

^a HOSPITAL UNIVERSITI SAINS MALAYSIA   (Malaysia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^c HAWLER MEDICAL UNIVERSITY   (Iraq)

^d INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

^e UNIVERSITI SULTAN ZAINAL ABIDIN   (Malaysia)

^f UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

ABCB1; cold pressor test; methadone; opiate substitution treatment; P glycoproteins; pain

Indexed keywords

ABCB1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN;

ADULT; COLD; DRUG EFFECTS; GENETICS; GENOTYPE; HUMAN; MALE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PAIN THRESHOLD; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; COLD TEMPERATURE; GENOTYPE; HUMANS; MALE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; P-GLYCOPROTEINS; PAIN THRESHOLD; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 85016180902     PISSN: 00296562     EISSN: 15389847     Source Type: Journal    
DOI: 10.1097/NNR.0000000000000204     Document Type: Article

References (58)

1. Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., & Gottesman, M. M. (1999). Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annual Review of Pharmacology and Toxicology, 39, 361-398. doi:10.1146/annurev.pharmtox.39.1.361
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3. Au, A., Aziz Baba, A., Goh, A. S., Wahid Fadilah, S. A., Teh, A., & Rosline, H., Ankathil, R. (2014). Association of genotypes and hap-lotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients. Biomedicine & Pharmacotherapy, 68, 343-349. doi:10.1016/j.biopha.2014.01.009
4. Baharom, N., Hassan, M. R., Ali, N., & Shah, S. A. (2012). Improvement of quality of life following 6 months of methadone maintenance therapy in Malaysia. Substance Abuse Treatment, Prevention, and Policy, 7, 32. doi:10.1186/1747-597x-7-32
5. Bart, G., Lenz, S., Straka, R. J., & Brundage, R. C. (2014). Ethnic and genetic factors in methadone pharmacokinetics: A population pharmacokinetic study. Drug and Alcohol Dependence, 145, 185-193. doi:10.1016/j.drugalcdep.2014.10.014
6. Belfer, I., Segall, S. K., Lariviere, W. R., Smith, S. B., Dai, F., Slade, G. G., Diatchenko, L. (2013). Pain modality- and sex-specific effects of COMT genetic functional variants. Pain, 154, 1368-1376. doi:10.1016/j.pain.2013.04.028
7. Bouër, R., Barthe, L., Philibert, C., Tournaire, C., Woodley, J., & Houin, G. (1999). The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: In vitro studies using the rat everted intestinal sac. Fundamental & Clinical Pharmacology, 13, 494-500. doi:10.1111/j.1472-8206.1999.tb00009.x
8. Cheek, D. J., Bashore, L., & Brazeau, D. A. (2015). Pharmacogenomics and implications for nursing practice. Journal of Nursing Scholarship, 47, 496-504. doi:10.1111/jnu.12168
9. Chen, A. C., Dworkin, S. F., Haug, J., & Gehrig, J. (1989). Human pain responsivity in a tonic pain model: Psychological determinants [Review]. Pain, 37, 143-160. doi:10.1016/0304-3959(89)90126-7
10. Cohen, J. (1992). A power primer. Psychological Bulletin, 112, 155-159. doi:10.1037/0033-2909.112.1.155
11. Coller, J. K., Barratt, D. T., Dahlen, K., Loennechen, M. H., & Somogyi, A. A. (2006). ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals. Clinical Pharmacology and Therapeutics, 80, 682-690. doi:10.1016/j. clpt.2006.09.011
12. Compton, P., Canamar, C. P., Hillhouse, M., & Ling, W. (2012). Hyperalgesia in heroin dependent patients and the effects of opi-oid substitution therapy. Journal of Pain, 13, 401-409. doi:10.1016/ j.jpain.2012.01.001
13. Compton, P., Charuvastra, V. C., & Ling, W. (2001). Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug and Alcohol Dependence, 63, 139-146. doi:10.1016/S0376-8716(00)00200-3
14. Compton, P., Geschwind, D. H., & Alarcón, M. (2003). Association between human μ-opioid receptor gene polymorphism, pain tolerance, and opioid addiction. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 121B, 76-82. doi:10.1002/ ajmg.b.20057
15. Crettol, S., Déglon, J. J., Besson, J., Croquette-Krokar, M., Hämmig, R., Gothuey, I., Eap, C. B. (2006). ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment. Clinical Pharmacology and Therapeutics, 80, 668-681. doi:10.1016/j.clpt.2006.09.012
16. Dennis, B. B., Bawor, M., Thabane, L., Sohani, Z., & Samaan, Z. (2014). Impact of ABCB1 and CYP2B6 genetic polymorphisms on metha-done metabolism, dose and treatment response in patients with opioid addiction: A systematic review and meta-analysis. PLOS ONE, 9, e86114. doi:10.1371/journal.pone.0086114
17. Etherton, J., Lawson, M., & Graham, R. (2014). Individual and gender differences in subjective and objective indices of pain: Gender, fear of pain, pain catastrophizing and cardiovascular reactivity. Applied Psychophysiology and Biofeedback, 39, 89-97. doi:10.1007/ s10484-014-9245-x
18. Farhoudi, M., Khalili, H., Karimzadeh, I., & Abbasian, L. (2015). Associated factors of drug-drug interactions of highly active antiretrovi-ral therapy: Report from a referral center. Expert Opinion on Drug Metabolism & Toxicology, 11, 471-479. doi:10.1517/ 17425255.2014.993606
19. Fujita, K., Ando, Y., Yamamoto, W., Miya, T., Endo, H., Sunakawa, Y., Sasaki, Y. (2010). Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer. Cancer Chemotherapy and Pharmacology, 65, 251-258. doi:10.1007/s00280-009-1029-2
20. Fung, K. L., & Gottesman, M. M. (2009). A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochimica et Biophysica Acta, 1794, 860-871. doi:10. 1016/j.bbapap.2009.02.014
21. Glynn, C. J., & Lloyd, J. W. (1976). The diurnal variation in perception of pain. Proceedings of the Royal Society of Medicine, 69, 369-372.
22. Haerian, B. S., Lim, K. S., Tan, H. J., Mohamed, E. H., Tan, C. T., Raymond, A. A., Mohamed, Z. (2011). Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients. Epileptic Disorders, 13, 65-75. doi:10.1684/epd.2011.0419
23. Hamzah, S., Teh,L.K., Siew,J.S., Ahmad, G., Wong,H.S., Zakaria,Z.A., Salleh, M. Z. (2014). Pharmacogenotyping of CYP3A5 in predicting dose-adjusted trough levels of tacrolimus among Malaysian kidney-transplant patients. Canadian Journal of Physiology and Pharmacology, 92, 50-57. doi:10.1139/cjpp-2013-0128
24. Hassan, H. E., Myers, A. L., Coop, A., & Eddington, N. D. (2009). Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: In vitro and in vivo evaluation. Journal of Pharmaceutical Sciences, 98, 4928-4940. doi:10.1002/jps.21770
25. Hay, J. L., White, J. M., Bochner, F., Somogyi, A. A., Semple, T. J., & Rounsefell, B. (2009). Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. Journal of Pain, 10, 316-322. doi:10.1016/j.jpain.2008.10.003
26. Henly, S. J. (2016). Individualizing nursing care in the omics era [Editorial]. Nursing Research, 65, 89-90. doi:10.1097/nnr.0000000000000156
27. Hung, C. C., Chiou, M. H., Teng, Y. N., Hsieh, Y. W., Huang, C. L., & Lane, H. Y. (2013). Functional impact of ABCB1 variants on interactions between P-glycoprotein and methadone. PLOS ONE, 8, e59419. doi:10.1371/journal.pone.0059419
28. Jannot, A. S., Essioux, L., & Clerget-Darpoux, F. (2004). Association in multifactorial traits: How to deal with rare observations? Human Heredity, 58, 73-81. doi:10.1159/000083028
29. Krishnan, S., Salter, A., Sullivan, T., Gentgall, M., White, J., & Rolan, P. (2012). Comparison of pain models to detect opioid-induced hyperalgesia. Journal of Pain Research, 5, 99-106. doi:10.2147/ JPR.S27738
30. Lee, M., Silverman, S. M., Hansen, H., Patel, V. B., & Manchikanti, L. (2011). A comprehensive review of opioid-induced hyperalgesia. Pain Physician, 14, 145-161.
31. Leschziner, G. D., Andrew, T., Pirmohamed, M., & Johnson, M. R. (2007). ABCB1 genotype and PGP expression, function and therapeutic drug response: A critical review and recommendations for future research. Pharmacogenomics Journal, 7, 154-179. doi:10.1038/sj.tpj.6500413
32. Lewis, G. N., Heales, L., Rice, D. A., Rome, K., & McNair, P. J. (2012). Reliability of the conditioned pain modulation paradigm to assess endogenous inhibitory pain pathways. Pain Research & Management, 17, 98-102.
33. Liang, D. Y., Liao, G., Lighthall, G. K., Peltz, G., & Clark, D. J. (2006). Genetic variants of the P-glycoprotein gene Abcb1b modulate opioid-induced hyperalgesia, tolerance and dependence. Phar-macogenetics and Genomics, 16, 825-835. doi:10.1097/01. fpc.0000236321.94271.f8
34. Lu, Y., Kham,S.K., Ariffin, H., Oei,A.M., Lin,H.P., Tan,A.M., Yeoh, A. E. (2014). Host genetic variants of ABCB1 and IL15 influence treatment outcome in paediatric acute lymphoblastic leukaemia. British Journal of Cancer, 110, 1673-1680. doi:10.1038/bjc.2014.7
35. Lua, P. L., & Talib, N. S. (2012). A 12-month evaluation of health-related quality of life outcomes of methadone maintenance program in a rural Malaysian sample. Substance Use & Misuse, 47, 1100-1105. doi:10.3109/10826084.2012.679840
36. Manan, M. M., Ali, S. M., Khan, M. A., Jafarian, S., & Hameed, M. A. (2013). Review on the demographic and social impact of methadone-medication therapy on Malaysian patients. Pakistan Journal of Pharmaceutical Sciences, 26, 841-846.
37. Meissner, K., Jedlitschky, G., Meyer zu Schwabedissen, H., Dazert, P., Eckel, L., Vogelgesang, S., Kroemer, H. K. (2004). Modulation of multidrug resistance P-glycoprotein 1 (ABCB1) expression in human heart by hereditary polymorphisms. Pharmacogenetics, 14, 381-385.
38. Mouly, S., Bloch, V., Peoc'h, K., Houze, P., Labat, L., Ksouda, K., Vorspan, F. (2015). Methadone dose in heroin-dependent patients: Role of clinical factors, comedications, genetic polymorphisms and enzyme activity. British Journal of Clinical Pharmacology, 79, 967-977. doi:10.1111/bcp.12576
39. Musa, R., Abu Bakar, A. Z., & Ali Khan, U. (2012). Two-year outcomes of methadone maintenance therapy at a clinic in Malaysia. Asia-Pacific Journal of Public Health, 24, 826-832. doi:10.1177/ 1010539511404396
40. Nielsen, C. S., Stubhaug, A., Price, D. D., Vassend, O., Czajkowski, N., & Harris, J. R. (2008). Individual differences in pain sensitivity: Genetic and environmental contributions. Pain, 136, 21-29. doi:10.1016/ j.pain.2007.06.008
41. Peles, E., Schreiber, S., Hetzroni, T., Adelson, M., & Defrin, R. (2011). The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment. Journal of Pain, 12, 41-50. doi:10.1016/ j.jpain.2010.04.009
42. Pud, D., Cohen, D., Lawental, E., & Eisenberg, E. (2006). Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy subjects. Drug and Alcohol Dependence, 82, 218-223. doi:10.1016/j.drugalcdep.2005.09.007
43. Racine, M., Tousignant-Laflamme, Y., Kloda, L. A., Dion, D., Dupuis, G., & Choinière, M. (2012). A systematic literature review of 10 years of research on sex/gender and experimental pain perception -part 1: Are there really differences between women and men? Pain, 153, 602-618. doi:10.1016/j.pain.2011.11.025
44. Ruscheweyh, R., Stumpenhorst, F., Knecht, S., & Marziniak, M. (2010). Comparison of the cold pressor test and contact thermode-delivered cold stimuli for the assessment of cold pain sensitivity. Journal of Pain, 11, 728-736. doi:10.1016/j.jpain.2009.10.016
45. Shavers, V. L., Bakos, A., & Sheppard, V. B. (2010). Race, ethnicity, and pain among the U.S. adult population. Journal of Health Care for the Poor and Underserved, 21, 177-220. doi:10.1353/ hpu.0.0255
46. Somogyi, A. A., Barratt, D. T., Ali, R. L., & Coller, J. K. (2014). Pharmacogenomics of methadone maintenance treatment [Review]. Pharmacogenomics, 15, 1007-1027. doi:10.2217/pgs.14.56
47. Subenthiran, S., Abdullah, N. R., Muniandy, P. K., Joseph, J. P., Cheong, K. C., Ismail, Z., & Mohamed, Z. (2013). G2677T polymorphism can predict treatment outcome of Malaysians with complex partial seizures being treated with Carbamazepine. Genetics and Molecular Research, 12, 5937-5944. doi:10.4238/2013.November.26.3
48. Suthandiram, S., Gan,G.G., Zain,S.M., Bee,P.C., Lian,L.H., Chang,K.M., Mohamed, Z. (2014). Effect of polymorphisms within metho-trexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies. Pharmacogenomics, 15, 1479-1494. doi:10.2217/pgs.14.97
49. Tang, K., Ngoi, S. M., Gwee, P. C., Chua, J. M., Lee, E. J., Chong, S. S., & Lee, C. G. (2002). Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics, 12, 437-450.
50. Teh, L. K., Lee, W. L., Amir, J., Salleh, M. Z., & Ismail, R. (2007). Single step PCR for detection of allelic variation of MDR1 gene (P-glycoprotein) among three ethnic groups in Malaysia. Journal of Clinical Pharmacy and Therapeutics, 32, 313-319. doi:10.1111/j.1365-2710.2007.00822.x
51. Teh, L. K., Mohamed, N. I., Salleh, M. Z., Rohaizak, M., Shahrun, N. S., Saladina, J. J., & Din, J. (2012). The risk of recurrence in breast cancer patients treated with tamoxifen: Polymorphisms of CYP2D6 and ABCB1. AAPS Journal, 14, 52-59. doi:10.1208/s12248-011-9313-6
52. Tournier, N., Chevillard, L., Megarbane, B., Pirnay, S., Scherrmann, J. M., & Declèves, X. (2010). Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). International Journal of Neuropsychopharmacology, 13, 905-915. doi:10.1017/ S1461145709990848
53. Wang, J. S., Ruan, Y., Taylor, R. M., Donovan, J. L., Markowitz, J. S., & DeVane, C. L. (2004). Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice. Psycho-pharmacology, 173, 132-138. doi:10.1007/s00213-003-1718-1
54. Yeap, L. L., Lim, K. S., Ng, C. C., Hui-Ping Khor, A., & Lo, Y. L. (2014). Slow carbamazepine clearance in a nonadherent Malay woman with epilepsy and thyrotoxicosis. Therapeutic Drug Monitoring, 36, 3-9. doi:10.1097/FTD.0000000000000024
55. Zahari, Z., Lee, C. S., Ibrahim, M. A., Musa, N., Yasin, M. A., Lee, Y. Y., Ismail, R. (2015). The opposing roles of IVS2+691 CC genotype and AC/AG diplotype of 118A>G and IVS2+691G>C of OPRM1 polymorphisms in cold pain tolerance among opioid-dependent Malay males on methadone therapy. Pain and Therapy, 4, 179-196. doi:10.1007/s40122-015-0041-y
56. Zahari, Z., Lee, C. S., Ibrahim, M. A., Musa, N., Yasin, M. A., Lee, Y. Y., & Ismail, R. (2016). Comparison of pain tolerance between opioid dependent patients on methadone maintenance therapy (MMT) and opioid naive individuals. Journal of Pharmacy & Pharmaceutical Sciences, 19, 127-136. doi:10.18433/J3NS49
57. Zahari, Z., Lee, C. S., Tan, S. C., Mohamad, N., Lee, Y. Y., & Ismail, R. (2015). Relationship between cold pressor pain-sensitivity and sleep quality in opioid-dependent males on methadone treatment. PeerJ, 3, e839. doi:10.7717/peerj.839
58. Zwisler, S. T., Enggaard, T. P., Noehr-Jensen, L., Mikkelsen, S., Verstuyft, C., Becquemont, L., Brosen, K. (2010). The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the OPRM1 and ABCB1 genes. Fundamental & Clinical Pharmacology, 24, 517-524. doi:10.1111/j.1472-8206.2009.00781.x